Nomination Committee prior to Orexo's 2009 Annual General Meeting


Nomination Committee prior to Orexo's 2009 Annual General Meeting

In accordance with the decision at the 2008 Annual General Meeting, the
composition of the Nomination Committee for the 2009 Annual General Meeting is
hereby announced.

At Orexo's Annual General Meeting on April 3, 2008, it was resolved that the
company shall have a Nomination Committee consisting of one representative for
each of the four largest shareholders in terms of the number of votes and the
chairman of the Board of Directors.

The Nomination Committee, whose tasks include providing proposals to the 2009
Annual General Meeting regarding chairman of the Meeting, board members,
chairman of the Board, board fees for the board members as well as remuneration
for committee work, if any, and fees to the company's auditor, comprises:
    • Björn Odlander, HealthCap 
    • Marc Philouze, Apax Partners
    • Antoine Papiernik, Sofinnova Partners
    • Annika Andersson, Fourth Swedish National Pension Fund (AP4), also
Chairman of the
      Nomination Committee 
    • Håkan Åström, Chairman of the Board of Orexo

The Nomination Committee represents in total approximately 50 percent of the
number of shares and votes in the company based on the most recent ownership
information known to Orexo. The Nomination Committee's proposals will be
presented in the notice to the Annual General Meeting 2009 and on Orexo's web
site, www.orexo.com.

Shareholders who want to contact the Nomination Committee, can send an e-mail to
johan.andersson@orexo.com (subject “Nomination Committee”) or by letter posted
to “Orexo's Nomination Committee,” Orexo AB, Box 303, SE-751 05 Uppsala.

The Annual General Meeting in Orexo will be held on Thursday, April 23, 2009 in
Stockholm.
Shareholders who want to have a matter addressed at the Annual General Meeting
2009 must submit such a proposal to the same address as above (subject “Annual
General Meeting 2008” for the e-mail and the letter, respectively) in sufficient
time prior to the announcement to convene the Meeting, which is expected to
occur at the beginning of March 2009. 

Future information reporting dates from Orexo:
Interim Report January - September 2008	November 10, 2008
Year-End Report 2008			February 17, 2009
Annual General Meeting 2009		April 23, 2009
Interim Report January - March 2009		May 6, 2009
Interim Report January - June 2009		August 21, 2009
Interim Report January - September 2009	November 10, 2009
For more information, please contact: 
Torbjörn Bjerke, President and CEO, Orexo AB
Tel: +46 (0)708-66 19 90
E-mail: torbjorn.bjerke@orexo.com
Claes Wenthzel, Executive Vice President and CFO, Orexo AB 
Tel: +46 (0)708-62 01 22 
E-mail: claes.wenthzel@orexo.com

Orexo AB (publ) may be required to disclose the information provided herein
pursuant to the Swedish Securities Markets Act. The information was provided for
public release on Thursday, October 23, 2008 at 10:00 a.m. CET.

Attachments

10232233.pdf